Ranitidine Hydrochloride Tablets IP 300 mg Manufacturer in India – Healthy Life Pharma Pvt. Ltd.

Ranitidine Hydrochloride Tablets IP 300 mg | Manufacturer
Product image for Ranitidine Hydrochloride Tablets IP 300 mg Manufacturer; contract manufacturing, oem & quality control.
Product Information
| Generic Name | Ranitidine Hydrochloride |
|---|---|
| Manufacturer | Healthy Life Pharma Pvt. Ltd. |
| HSN Code | 30049033 |
| Pharmacopoeia | IP |
| Product Type | Tablet |
| Category | Gastrointestinal drugs – Acid Suppression |
| Subcategory | Acid Suppression |
| Active Ingredient | Ranitidine Hydrochloride |
| Strength | 300 mg |
| Dosage Form | Tablet |
| Pack Size | 10 x 10 Tablets / Box (Alu-Alu / Blister) |
| Route of Administration | Oral |
| Prescription Required | Yes |
| Therapeutic Category | Gastrointestinal drugs – Acid Suppression |
Medicine Details & Safety
| Short Description | Healthy Life Pharma invites contract and third-party manufacturing enquiries for Ranitidine Hydrochloride Tablets IP 300 mg from pharmaceutical marketing companies, institutional buyers and brand owners. Production specifications, batch size and packaging are agreed against the approved product dossier and purchase requirements. | ||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Approved Uses / Indications | 1. Symptomatic relief and healing of erosive gastroesophageal reflux disease (GERD). 2. Treatment of gastric ulcers, duodenal ulcers, and NSAID-associated mucosal injury. | ||||||||||||||||||||||||
| Full Description | Healthy Life Pharma invites contract and third-party manufacturing enquiries for Ranitidine Hydrochloride Tablets IP 300 mg from pharmaceutical marketing companies, institutional buyers and brand owners. Production specifications, batch size and packaging are agreed against the approved product dossier and purchase requirements. Product technical specifications
Product technical specifications
Manufacturing capabilities and infrastructureFor Ranitidine Hydrochloride Tablets IP 300 mg, assess the approved formulation process, equipment suitability, batch scale and in-process controls for the Tablet presentation. Confirm environmental requirements and validated process before production.Quality control and assuranceRequest the approved finished-product specification for Ranitidine Hydrochloride Tablets IP 300 mg, including applicable identity, assay, uniformity and performance tests for the Tablet presentation. Confirm analytical methods, acceptance criteria and batch release documentation, including COA availability.Primary and secondary packagingThe catalogue pack for Ranitidine Hydrochloride Tablets IP 300 mg is 10 x 10 Tablets / Box (Alu-Alu / Blister). Confirm primary packaging compatibility, stability evidence, artwork, batch coding and leaflet requirements against the approved specification.Contract manufacturing and private labelSubmit the target market, strength, pharmacopoeial specification, forecast volume and brand artwork. Agree feasibility, batch size, quality agreement, production schedule and release criteria before execution. | ||||||||||||||||||||||||
| Dosage Instructions | Administer orally 30 to 60 minutes before morning meals (or as prescribed for antacids, after meals and at bedtime). Swallow whole with water; do not crush or chew enteric-coated tablets. | ||||||||||||||||||||||||
| Side Effects | Common: Headache, diarrhea, constipation, abdominal discomfort, nausea. Uncommon: Flatulence, dry mouth, dizziness, transient transaminase elevation. Rare: Hypomagnesemia, Clostridioides difficile-associated diarrhea, subacute cutaneous lupus. | ||||||||||||||||||||||||
| Warnings and Precautions | Masking Malignancy: Symptomatic relief does not preclude presence of gastric malignancy; perform diagnostic workup if alarm symptoms exist. Long-Term Bone Density: Extended chronic use may slightly elevate risk of osteoporosis-related fractures; ensure adequate calcium and vitamin D intake. | ||||||||||||||||||||||||
| Contraindications | 1. Known hypersensitivity to Ranitidine Hydrochloride or substituted benzimidazoles / antacids. 2. Severe electrolyte imbalances (for magnesium/aluminum antacids in renal failure). 3. Concurrent administration with rilpivirine-containing products. | ||||||||||||||||||||||||
| Drug Interactions | 1. pH-Dependent Bioavailability Drugs (Ketoconazole, Itraconazole, Iron Salts): Reduced absorption due to elevated gastric pH. 2. Clopidogrel: Potential attenuation of antiplatelet activation by certain proton pump inhibitors. 3. Digoxin & Methotrexate: Elevated serum concentrations requiring dosage monitoring. |
Frequently Asked Questions
| Question | Answer |
|---|---|
| Can I request third-party manufacturing for Ranitidine Hydrochloride Tablets IP 300 mg? | Submit your brand, quantity and packaging requirements for manufacturing feasibility review. |
| Which pharmacopoeial standard applies for Ranitidine Hydrochloride Tablets IP 300 mg? | The source specification is IP; confirm the required standard before contracting. |
| What quality tests are applicable for Ranitidine Hydrochloride Tablets IP 300 mg? | Request the approved finished-product specification and batch testing plan. |
| Can packaging be customized for Ranitidine Hydrochloride Tablets IP 300 mg? | Submit artwork and pack requirements for technical and regulatory review. |
| How do I request a manufacturing quotation for Ranitidine Hydrochloride Tablets IP 300 mg? | Provide forecast volume, target market, strength and packaging requirements. |
Related Products
✚
Ranitidine Hydrochloride Tablets BP 150 mg ExporterView product →
✚
Ranitidine Hydrochloride Tablets BP 150 mg ManufacturerView product →
✚
Ranitidine Hydrochloride Tablets BP 150 mg SupplierView product →
✚
Ranitidine Hydrochloride Tablets IP 150 mg ExporterView product →
✚
Ranitidine Hydrochloride Tablets IP 150 mg ManufacturerView product →
✚
Ranitidine Hydrochloride Tablets IP 150 mg SupplierView product →
✚
Ranitidine Hydrochloride Tablets IP 300 mg ExporterView product →
✚
Ranitidine Hydrochloride Tablets IP 300 mg SupplierView product →
✚
Ranitidine Hydrochloride Tablets USP 300 mg ExporterView product →
✚
Ranitidine Hydrochloride Tablets USP 300 mg ManufacturerView product →
✚
Ranitidine Hydrochloride Tablets USP 300 mg SupplierView product →
✚
Cimetidine Tablets USP 200 mg ExporterView product →
Latest Posts
✚
WHO GMP certfied Glibenclamide Metformin SR TabletsRead article →✚
WHO GMP certfied Frusemide Tablets ManufacturerRead article →✚
Folic Acid Niacinamide Tablets ManufacturerRead article →✚
WHO GMP certfied Folic Acid Tablets ManufacturerRead article →✚
WHO GMP certfied Fluconazole Tablets ManufacturerRead article →✚
WHO GMP certfied Ferrous Sulphate with folic acid TabletsRead article →✚
WHO GMP certfied iron with folic acid Tablets ManufacturerRead article →✚
WHO GMP certfied Ferrous Sulphate Tablets ManufacturerRead article →